Cervical cancer diagnostic device

ZILICO has received EC certification from its Notified Body for the ZedScan cervical cancer diagnostics device, which is said to offer faster and more accurate detection of cervical neoplasia in real-time, enabling clinicians to improve patient management.

The ZedScan system is used alongside colposcopy on women identified with an abnormal smear result. It can offer clinical benefits by identifying the optimum biopsy site, reducing the number of cervical biopsies required while also facilitating a wider use of ‘select & treat’.

The system, which is both safe and painless, consists of a portable hand-held device and docking station, software application and a single-use EIS sensor. Five clinical trials in the UK and EU have supported the clinical efficacy of ZedScan, including a pivotal European trial of 429 women in 2011 across three hospitals in the UK and Ireland.

 

Other news

Upcoming Events

BES Healthcare Seminar

Imperial Hotel, London
5th and 6th September 2018

Study Day 2018 – What could possibly go wrong? Lessons learned in decontamination

Birmingham Botanical Gardens
17th September 2018

British Orthopaedic Association Century Congress

ICC Birmingham
25th - 28th September 2018

Infection Prevention 2018

Scottish Events Campus, Glasgow
30th September - 2nd October 2018

iM Med Study Day – Tuesday 9th October 2018

The Queens (Hotel) City Square
9th October 2018

Latest Issue

Clinical Services Journal

Clinical Services Journal

Aug 2018

Keeping it simple for you and your staff

Register now to apply for regular copies of Clinical Services Journal and free access to premium content, as well as our regular newsletters.

CSJ Supplements

CSJ Supplements

Aug 2018

Sunoptic’s brightest LED headlight

Register now to apply for regular copies of CSJ Supplements and free access to premium content, as well as our regular newsletters.